Dana Point, CA, United States
Dana Point, CA, United States

Time filter

Source Type

News Article | April 24, 2017
Site: www.businesswire.com

TORONTO--(BUSINESS WIRE)--Evolution Technology Resources Inc. (OTC: ETKR) a firm with its office in Toronto, Canada, received acquisition financing from investment firm Eliseo Partners to acquire an operational, licensed and revenue producing online casino as a foundation to build a portfolio of brands in the growing online gambling and social gaming market. The global online gambling market is currently worth around $37 billion a year, as about 85 nations across the world have chosen to legali


TORONTO--(BUSINESS WIRE)--Evolution Technology Resources, Inc. (OTC: ETKR), has announced it is complying with the filing regulations of the OTC Markets and will be current in its submissions thereto within the next week. The Company also took the added measure of re-filing its past reports dating back to the first quarter of 2015 for purposes of consistency and proper disclosure. ETKR plans to on having its financial statements audited in the near future in order to qualify as a fully-reporting issuer and these filings and re-filings will make that process much more efficient, both for time and cost savings. Evolution Technology Resources, Inc. is a business development stage company that is focused on acquiring intellectual property and assets for the manufacturing of biomass processing equipment for the production of energy. The Company intends to acquire intellectual property and capability to produce technology for the biomass-to-energy sector. Safe Harbor: This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.


Pietre-Cambacedes L.,Électricité de France | Quinn E.L.,Technology Resources | Hardin L.,U.S. Nuclear Regulatory Commission
IFAC Proceedings Volumes (IFAC-PapersOnline) | Year: 2013

This paper provides an overview of the work of the International Electrotechnical Commission (IEC) on the development of a series of standards dealing with the cyber security of nuclear power plant (NPP) instrumentation and control (I&C) systems. In particular, the status and content of the first, top level document of the series, IEC 62645, is described. A more recent draft, IEC 62859, dealing with the coordination between safety and cyber security aspects, is also presented. Future work and perspectives associated with this new series of standards are finally discussed. © IFAC.


Schrader K.J.,Pacific Gas and Electric Company | Hefler J.W.,Altran GmbH | Quinn E.L.,Technology Resources
9th International Topical Meeting on Nuclear Plant Instrumentation, Control, and Human-Machine Interface Technologies, NPIC and HMIT 2015 | Year: 2015

Diablo Canyon Power Plant (DCPP) is replacing the existing digital Westinghouse Eagle 21 Process Protection System (PPS) to address obsolescence issues. Eagle 21 was installed in 1994 to replace the original analog Westinghouse 7100 PPS. The PPS replacement design is based on a combination of the Invensys Tricon VI0 programmable logic controller and the Westinghouse Advanced Logic System field programmable gate array digital instrumentation and control devices. The License Amendment for replacement of the Eagle 21 PPS was submitted to the NRC on October 26, 2011. Key to submittal of the PPS replacement LAR was resolution of the need for Diversity and Defense-in-Depth (D3) in the replacement design to mitigate the potential for a common design error to disable redundant channels of the protection systems through common-cause failure (CCF). The PG&E PPS Replacement Project D3 Assessment Topical Report was submitted to the NRC in April, 2010, and approved in April, 2011. This paper discusses the architecture of the PPS replacement design and the methodology by which PG&E assessed the diversity requirements of the Diablo Canyon Power Plant (DCPP) digital PPS relative to current regulations and guidance, and developed a design with sufficient built-in diversity to meet USNRC DI&C ISG-02 Staff Position 1 without a Diverse Actuation System (DAS).


Liming J.K.,ABSG Consulting | Quinn E.L.,Technology Resources
9th International Topical Meeting on Nuclear Plant Instrumentation, Control, and Human-Machine Interface Technologies, NPIC and HMIT 2015 | Year: 2015

This paper summarizes an updated process for risk-informed surveillance frequency control program (RI-SFCP) implementation at nuclear power stations based on lessons learned in recent years. Since 2008, the authors of this paper have played significant roles in implementing industry initiative 5b RI-SFCPs for 20 nuclear power units operated by 8 nuclear power utility companies. These programs include selection and prioritization of specific target surveillance test interval extensions; and development, review, and implementation of surveillance test risk informed documented evaluation (STRIDE) packages designed to support extension of conventional surveillance requirement test intervals, in accordance with "Risk-Informed Technical Specifications Initiative 5b, Risk-Informed Method for Control of Surveillance Frequencies, Industry Guideline," NEI 04-10, Revision 1 [1]. The scope of work associated with STRIDE development includes probabilistic risk assessment (PRA) case studies, deterministic assessment (DA) evaluations, and, where required, instrument drift evaluation (IDE). The STRIDE implementation efforts have also included support of independent decision-making panel (IDP) meetings at the implementing power stations and IDP member training. The purpose of this paper is to provide a presentation of a refined process for STRIDE development with a focus on instrumentation and control systems based on author experience, which includes support for the development of over 100 plant STRIDES. This paper outlines a framework for practical implementation of an RI-SFCP within the context of an integrated risk-informed performance-based regulation application program with emphasis on instrumentation and control systems.


Thomas K.D.,Idaho National Laboratory | Quinn E.L.,Technology Resources | Mauck J.L.,Technology Resources | Bockhorst R.M.,Technology Resources
9th International Topical Meeting on Nuclear Plant Instrumentation, Control, and Human-Machine Interface Technologies, NPIC and HMIT 2015 | Year: 2015

The nuclear industry has been slow to incorporate digital sensor technology into nuclear plant designs due to concerns with digital qualification issues. However, the benefits of digital sensor technology for nuclear plant instrumentation are substantial in terms of accuracy and reliability. Improved accuracy results from the superior operating characteristics of digital sensors. These include improvements in sensor accuracy and drift and other related parameters which reduce total loop uncertainty and thereby increase safety and operating margins. Similarly, improved sensor reliability is illustrated with a sample calculation for determining the probability of failure on demand, an industry standard reliability measure. This looks at equivalent analog and digital temperature sensors to draw the comparison. The results confirm substantial reliability improvement with the digital sensor, due in large part to ability to continuously monitor the health of a digital sensor such that problems can be immediately identified and corrected. This greatly reduces the likelihood of a latent failure condition of the sensor at the time of a design basis event. Notwithstanding the benefits of digital sensors, there are certain qualification issues that are inherent with digital technology and these are described in the report. One major qualification impediment for digital sensor implementation is software common cause failure (SCCF).


Schrader K.J.,Pacific Gas and Electric Company | Hefler J.W.,Altran GmbH | Quinn E.L.,Technology Resources
9th International Topical Meeting on Nuclear Plant Instrumentation, Control, and Human-Machine Interface Technologies, NPIC and HMIT 2015 | Year: 2015

This paper provides a summary of the preparation of a License Amendment Request (LAR) for replacement of the existing Diablo Canyon Power Plant (DCPP) Eagle 21 digital Process Protection System (PPS) by Pacific Gas & Electric Company (PG&E) using US Nuclear Regulatory Commission (USNRC) Digital I&C (DI&C) Interim Staff Guidance (ISG) document ISG-06, Licensing Process [1]. The USNRC has designated the LAR for the DCPP PPS replacement project as the pilot application for use of DI&C ISG-06. DI&C ISG-06, Revision 1, issued for use on January 19, 2011, describes the licensing process the NRC staff may use to review an LAR for a DI&C modification. The LAR [2] for the replacement of the Eagle 21 PPS was submitted to the NRC on October 26, 2011, was accepted for review [3] on January 13, 2012, and is currently under review with approval expected in late 2015. A more detailed review of the specific PPS replacement design including the Defense-In-Depth and Diversity approach is provided in another paper being presented at this conference [12]. The use of pre-application (Phase 0) public meetings with the NRC staff to ensure the PPS replacement design adequately addressed NRC criteria was instrumental to development of the proposed PPS replacement design. This paper discusses the topics discussed in the Phase 0 meetings and the approach utilized by PG&E for the Phase 0 public meetings to support efficient development of the proposed PPS replacement design. PG&E developed a PPS Replacement diversity and defense-in-depth (D3) Assessment Topical Report [4] that was submitted to NRC in 2010 and approved [5] in 2011. This paper discusses the PG&E use of the D3 assessment to evaluate and optimize the initial PPS replacement design prior to submittal of the design to the NRC for approval. The PG&E experience with preparation of the LAR contents and supporting documents and lessons learned during the detailed design and verification phase is discussed.


Gill M.,Technology Resources | Garber M.J.,Technology Resources | Hua Y.,Technology Resources | Jenke D.,Technology Resources
Journal of Chromatographic Science | Year: 2010

Tinuvin 770 is a light stabilizer present in numerous polymers utilized in medical or pharmaceutical applications (e.g., manufacturing, packaging, delivery systems and devices). Under conditions of use, Tinuvin 770 and its related substances may leach from the polymers and accumulate in pharmaceutical products that are administered to subjects to produce a therapeutic benefit. In order to establish the amounts of Tinuvin 770 that may be extracted from such systems and devices, sensitive and selective analytical methodologies are required. A liquid chromatographic method with tandem mass spectrometric detection (LC-MS-MS; API-ES, positive ion mode) has been developed for the purpose of quantitating Tinuvin 770 and a related substance at low concentrations [200 ng/mL (ppb) or less] in aqueous extracting media. Issues related to injection-to-injection carryover and sample matrix effects were mitigated by the addition of potassium chloride to the test samples, where the potassium ion increases Tinuvin solubility via a "salting in" effect. The developed method was validated for this application by assessing performance characteristics including accuracy, response linearity, precision, specificity, and solution stability. The validated method is suitable for the quantitation of these analytes in the concentration range of 1-200 ng/mL.


News Article | March 1, 2017
Site: www.prnewswire.com

TAMPA, Fla., March 1, 2017 /PRNewswire/ -- On February 1st, National HR technology consulting firm, Benefit Technology Resources (BTR), LLC, celebrated its nine-year anniversary. Over the past nine years, BTR has grown to become one of the leading independent HR technology consulting firm...


KINGSPORT, Tenn., Feb. 14, 2017 (GLOBE NEWSWIRE) -- ITL Pharma, Inc. (ITL), a LIAS Research Company, today announced awarding of a United States Patent (US 9,526,701) titled: "Sustained Drug Release and Improved Product Stability Using Non-Covalent Particle Coating Methods." This "umbrella" patent provides a novel approach to drug delivery, allowing for extended product stability and controlled release of the API. TriThroid® (T3, Liothyronine, Na) is the lead product in the pipeline of products utilizing this technology. TriThroid®, now through Phase II clinical trials, provides for once-per-day dosing to fully replace thyroxine (T4) based products and is projected to be especially effective in hypothyroid patients that cannot effectively convert T4 to T3, by providing the active hormone (T3) directly to thyroid hormone target tissues. "This new Patent is a significant break-through in providing shelf-stable products with sustained drug release and pH dependent PK profiles,” said Dr. Keith R. Latham, ITL's Chief Executive Officer. "This new Patent also provides a critical advance in the delivery of additional drugs in our pipeline including treatments for Cancer, Thyroid, Parkinson's, Alzheimer's and Inflammatory Diseases." About ITL Pharma ITL Pharma, Inc. is a privately held US Pharmaceutical company headquartered in Kingsport, Tennessee. Established in VA in 1996 by merger of Inovar Chemicals, Innovative Technologies and Technology Resources, ITL now focuses on new drug discovery and development with 22 new pipeline drugs in 8 therapeutic arenas (www.ITLPharmaceuticals.com). ITL has now completed Phase II clinical trials on TriThroid®, a sustained release, sustained effects, once-per-day dosing product containing Liothyronine (T3) as the API. This prescription product will replace Levothyroxine (T4) products in a $3.4 Billion market. ITL's vertical integration program anticipates Partnering with companies specializing in market launch and World-Wide distribution and sales. About LIAS Research Latham Institute of Advanced Science (LIAS), the parent company for ITL Pharma, provides program integration and management resources to the LIAS Family of Companies. LIAS companies have a pipeline of new prescription drugs and marketed Over the Counter (OTC) products. LIAS CEO, Gina Garland, stated: “We are very pleased with the outstanding progress ITL has made in the treatment of hypothyroidism and other diseases.”

Loading Technology Resources collaborators
Loading Technology Resources collaborators